Molecular modeling study of novel lancifolamide bioactive molecule as an inhibitor of acetylcholinesterase (ache), herpes simplex virus (hsv-1), and anti-proliferative proteins

HIGHLIGHTS

  • who: Malik Saadullah et al. from the Department of Pharmaceutical Chemistry, Government College University, Jeddah, Saudi Arabia have published the Article: Molecular Modeling Study of Novel Lancifolamide Bioactive Molecule as an Inhibitor of Acetylcholinesterase (AChE), Herpes Simplex Virus (HSV-1), and Anti-proliferative Proteins, in the Journal: Molecules 2022, 5480 of /2022/
  • what: This study is focused on the anti-Alzheimer's and antiviral activity of C. lancifolius and lancifolamide (LFD).

SUMMARY

    The ligand-target protein interaction studies were accomplished by molecular docking using a transcriptional regulator 4EY7 (Human acetylcholinesterase co . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?